Terms: = Skin cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL
168 results:
1. VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives.
Malekan M; Haass NK; Rokni GR; Gholizadeh N; Ebrahimzadeh MA; Kazeminejad A
Life Sci; 2024 May; 345():122563. PubMed ID: 38508233
[TBL] [Abstract] [Full Text] [Related]
2. Epidemiological trends in cutaneous lymphomas in Greece.
Kaliampou S; Nikolaou V; Niforou A; Kotsiopoulou I; Gerochristou M; Papanikolaou A; Kanellis G; Papadavid E; Tsimpidakis A; Pouliou E; Economaki E; Panou E; Nikolaou C; Stratigos AJ; Naska A; Marinos L
Eur J Dermatol; 2023 Dec; 33(6):664-673. PubMed ID: 38465548
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological and immunohistochemical characteristics of bullous pilomatricoma: a retrospective, single-center study, and comparison with ordinary pilomatricoma.
Nam KH; Lee SK; Lee IJ; Park J; Yun SK
An Bras Dermatol; 2024; 99(3):362-369. PubMed ID: 38350760
[TBL] [Abstract] [Full Text] [Related]
4. Decoding the synergistic potential of MAZ-51 and zingerone as therapy for melanoma treatment in alignment with sustainable development goals.
Letsoalo K; Nortje E; Patrick S; Nyakudya T; Hlophe Y
Cell Biochem Funct; 2024 Mar; 42(2):e3950. PubMed ID: 38348768
[TBL] [Abstract] [Full Text] [Related]
5. Health-related quality of life and its influencing factors in patients with primary cutaneous B-cell lymphomas: A multicentric study in 100 patients.
Schirren AEC; Albrecht JD; Melchers S; Weiß C; Büttner S; Dippel E; Gosmann J; Jonak C; Klemke CD; Laturnus-Chang M; Livingstone E; Mitteldorf C; Schummer P; Stadler R; Stranzenbach R; Weyer-Fahlbusch SS; Wobser M; Ziemer M; Nicolay JP
J Eur Acad Dermatol Venereol; 2024 May; 38(5):954-966. PubMed ID: 38279594
[TBL] [Abstract] [Full Text] [Related]
6. Tumor Cell Lysate-Based Multifunctional Nanoparticles Facilitate Enhanced mRNA Delivery and Immune Stimulation for Melanoma Gene Therapy.
Huang J; Wang K; Wu S; Zhang J; Chen X; Lei S; Wu J; Men K; Duan X
Mol Pharm; 2024 Jan; 21(1):267-282. PubMed ID: 38079527
[TBL] [Abstract] [Full Text] [Related]
7. Characteristics of Primary Cutaneous Lymphoma in Italy: A Tertiary Care, Single-Center Study.
D'Onghia M; Cartocci A; Calabrese L; Maio D; Sirchio A; Erasti M; Tognetti L; Rubegni P; Bocchia M; Cencini E; Fabbri A; Cinotti E
Curr Oncol; 2023 Nov; 30(11):9813-9823. PubMed ID: 37999132
[TBL] [Abstract] [Full Text] [Related]
8. Epidemiology of mature T/NK-cell lymphomas in Germany - A representative cross-sectional study based on SHI claims data.
Assaf C; Dobos G; Zech IM; Doess A; May M; Jadasz J
J Dtsch Dermatol Ges; 2023 Nov; 21(11):1320-1327. PubMed ID: 37845021
[TBL] [Abstract] [Full Text] [Related]
9. Transcriptional landscape of Kaposi sarcoma tumors identifies unique immunologic signatures and key determinants of angiogenesis.
Ramaswami R; Tagawa T; Mahesh G; Serquina A; Koparde V; Lurain K; Dremel S; Li X; Mungale A; Beran A; Ohler ZW; Bassel L; Warner A; Mangusan R; Widell A; Ekwede I; Krug LT; Uldrick TS; Yarchoan R; Ziegelbauer JM
J Transl Med; 2023 Sep; 21(1):653. PubMed ID: 37740179
[TBL] [Abstract] [Full Text] [Related]
10. pcl/gelatin nanofibers embedded with doxorubicin-loaded mesoporous silica nanoparticles/silver nanoparticles as an antibacterial and anti-melanoma cancer.
Tavira M; Mousavi-Khattat M; Shakeran Z; Zarrabi A
Int J Pharm; 2023 Jul; 642():123162. PubMed ID: 37343778
[TBL] [Abstract] [Full Text] [Related]
11. Pediatric Primary Cutaneous Lymphoma in China: A Retrospective Study.
Zhang C; Jiang Y; Xu X; Sun J; Chen H
Dermatology; 2023; 239(4):553-564. PubMed ID: 37231916
[TBL] [Abstract] [Full Text] [Related]
12. Primary cutaneous lymphomas: exploration of 10-year data from supraregional mutlidisciplinary team meetings in Glasgow, UK.
McCusker S; Ngu I
Clin Exp Dermatol; 2023 Aug; 48(9):1036-1039. PubMed ID: 37140442
[TBL] [Abstract] [Full Text] [Related]
13. Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years.
Falkenhain-López D; Muniesa C; Estrach MT; Morillo-Andújar M; Peñate Y; Acebo E; Pujol RM; García-Muret MP; Machan S; Medina S; Botella-Estrada R; Fernández de Misa R; Blanes M; Flórez A; Pérez-Paredes G; Izu R; Yanguas I; Silva-Díaz E; Pérez-Ferriols A; Prieto-Torres L; Zayas A; Parera-Amer ME; Pérez A; Aspe L; Román C; Sánchez-Caminero MP; Bassas-Vila J; Domínguez-Auñón JD; Calzado L; Navedo M; Ortiz-Prieto A; Servitje O; Polo-Rodríguez I; Torres I; Hernández-Hernández MN; Mitxelena-Eceiza J; García-Vázquez A; García-Doval I; Ortiz-Romero PL
Actas Dermosifiliogr; 2023 Apr; 114(4):291-298. PubMed ID: 36529273
[TBL] [Abstract] [Full Text] [Related]
14. Vascular endothelial growth factor-C in activating vascular endothelial growth factor receptor-3 and chemokine receptor-4 in melanoma adhesion.
Hlophe YN; Joubert AM
J Cell Mol Med; 2022 Dec; 26(23):5743-5754. PubMed ID: 36398426
[TBL] [Abstract] [Full Text] [Related]
15. Selective anti-cancer activity against melanoma cells using 3-
Jamshidi-Adegani F; Vakilian S; Al-Hashmi S; Al-Kindi J; Rehman NU; Al-Sinani Y; Ghaemi S; Alam K; Anwar MU; Csuk R; Al-Harrasi A
Nat Prod Res; 2023 Jun; 37(12):2049-2054. PubMed ID: 36008779
[TBL] [Abstract] [Full Text] [Related]
16. Primary cutaneous lymphoma patients seen at a referral dermatological centre in 1 year: A single-centre observational retrospective cohort study of the diagnoses and staging, comorbidities and associated symptoms, treatment performed and clinical course.
Macagno N; Mastorino L; Rubatto M; Avallone G; Merli M; Agostini A; Fava P; Ribero S; Quaglino P
J Eur Acad Dermatol Venereol; 2022 Dec; 36(12):2388-2392. PubMed ID: 35881645
[TBL] [Abstract] [Full Text] [Related]
17. Electrospun Membranes Designed for Burst Release of New Gold-Complexes Inducing Apoptosis of Melanoma Cells.
Guadagno L; Raimondo M; Vertuccio L; Lamparelli EP; Ciardulli MC; Longo P; Mariconda A; Della Porta G; Longo R
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806152
[TBL] [Abstract] [Full Text] [Related]
18. skin cancer biology and barriers to treatment: Recent applications of polymeric micro/nanostructures.
Khan NH; Mir M; Qian L; Baloch M; Ali Khan MF; Rehman AU; Ngowi EE; Wu DD; Ji XY
J Adv Res; 2022 Feb; 36():223-247. PubMed ID: 35127174
[TBL] [Abstract] [Full Text] [Related]
19. Cutaneous B-cell lymphomas: Update on diagnosis, risk-stratification, and management.
Fava P; Roccuzzo G; Alberti-Violetti S; Grandi V; Pileri A; Pimpinelli N; Berti E; Quaglino P
Presse Med; 2022 Mar; 51(1):104109. PubMed ID: 35026390
[TBL] [Abstract] [Full Text] [Related]
20. Live imaging of neolymphangiogenesis identifies acute antimetastatic roles of dsRNA mimics.
Olmeda D; Cerezo-Wallis D; Mucientes C; Calvo TG; Cañón E; Alonso-Curbelo D; Ibarz N; Muñoz J; Rodriguez-Peralto JL; Ortiz-Romero P; Ortega S; Soengas MS
EMBO Mol Med; 2021 Dec; 13(12):e12924. PubMed ID: 34762341
[TBL] [Abstract] [Full Text] [Related]
[Next]
